No interaction between BIL and PPIs is anticipated.
PPIs are inhibitors of CYP 450, and this explains many of their drug-drug interactions. Furthermore, PPIs also inhibit P-gp, but this effect does not appear to be clinically relevant.
BIL is not metabolised and is unlikely to be affected by concomitant PPI therapy.
